Genetic Technologies Limited
METHODS OF ASSESSING RISK OF DEVELOPING A SEVERE RESPONSE TO CORONAVIRUS INFECTION
Last updated:
Abstract:
The present disclosure relates to methods and systems for assessing the risk of a human subject developing a severe response to a Coronavirus infection, such as a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus infection.
Status:
Application
Type:
Utility
Filling date:
8 Feb 2022
Issue date:
4 Aug 2022